Question 1

What is Brukinsa?

Accepted Answer

Brukinsa belongs to a class of drugs known as kinase inhibitors. It works by blocking the action of a specific protein called Bruton's tyrosine kinase, which signals certain cancer cells to multiply and survive.

By inhibiting this protein, the medication helps to slow or stop the progression of the disease. This targeted approach focuses on specific pathways within cells to interfere with their development.

Question 2

What is Brukinsa used for?

Accepted Answer

Brukinsa is used to treat the following conditions:

mantle cell lymphoma

Waldenström macroglobulinemia

chronic lymphocytic leukemia

and others

Question 3

How does Brukinsa work?

Accepted Answer

Mechanism of Action

Brukinsa belongs to a class of medications known as Bruton's tyrosine kinase (BTK) inhibitors. It is designed to target and interfere with the signaling pathways that allow certain blood cancers to progress.

Targeting B-cells

The medication works by focusing on B-cells, which are a type of white blood cell. In healthy individuals, B-cells help the immune system fight infections. However, in people with certain types of lymphoma or leukemia, these B-cells become cancerous and multiply uncontrollably.

Blocking the BTK Protein

Inside these cancerous B-cells is a protein called Bruton's tyrosine kinase. This protein acts as a signaling molecule that tells the cancer cells to grow, divide, and stay alive. Brukinsa works by:

Binding to the BTK protein.

Blocking the signals that the protein sends to the rest of the cell.

Preventing the cancer cells from multiplying and spreading.

By inhibiting this specific protein, the drug helps to reduce the number of cancer cells in the body and may lead to the death of existing cancer cells.

Question 4

What are the active ingredients in Brukinsa?

Accepted Answer

The active ingredient in Brukinsa is zanubrutinib .

Question 5

What are the side effects of Brukinsa?

Accepted Answer

Common side effects of Brukinsa may include:

diarrhea

fatigue

muscle pain

and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Brukinsa?

Accepted Answer

Brukinsa belongs to the BTK inhibitor drug class.

Question 7

What is the dosage of Brukinsa and how do I take it?

Accepted Answer

Administration Instructions

Brukinsa is taken by mouth, usually once or twice a day. It is important to follow the schedule prescribed by your healthcare provider and take the medication at approximately the same time each day.

How to swallow

The capsules must be swallowed whole with water. Do not chew, crush, or open the capsules, as this may affect how the drug is absorbed into your system.

Food considerations

You can take Brukinsa with or without food. Your choice does not typically affect how the medication works.

Missed Doses

If you miss a dose, take it as soon as you remember on the same day. If you do not realize you missed the dose until the following day, skip the missed dose and continue with your next regularly scheduled dose. You should not take extra capsules to make up for a dose you missed.

Question 8

Is Brukinsa safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Brukinsa can cause harm to an unborn baby. Based on animal studies and the way the medication works, it may lead to fetal harm when administered to a pregnant woman. It is important to discuss pregnancy status and plans with a healthcare provider before starting treatment.

To prevent pregnancy during treatment, the following measures are generally advised:

Females of reproductive potential should use effective birth control during treatment and for at least one week after the last dose.

Males with female partners of reproductive potential should use effective birth control during treatment and for at least one week after the last dose.

If pregnancy occurs while taking this medication, it should be reported to a healthcare provider immediately.

Breastfeeding

There is no information on whether Brukinsa is present in human breast milk or how it might affect a nursing child. Due to the risk of serious adverse reactions, breastfeeding is not recommended during treatment and for at least two weeks after the final dose.

Question 9

What forms and strengths does Brukinsa come in?

Accepted Answer

Brukinsa is supplied as a capsule to be taken by mouth. It is intended to be swallowed whole and can be administered with or without food.

Oral capsule

Question 10

What is the FDA approval status of Brukinsa?

Accepted Answer

FDA Approved Indications

Brukinsa is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with the following conditions:

Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL): Approved for use in adult patients.

Waldenström’s Macroglobulinemia (WM): Approved for use in adult patients.

Mantle Cell Lymphoma (MCL): Approved for patients who have received at least one prior therapy.

Marginal Zone Lymphoma (MZL): Approved for patients with relapsed or refractory disease who have received at least one prior anti-CD20-based regimen.

Follicular Lymphoma (FL): Approved for use in combination with obinutuzumab for patients with relapsed or refractory disease after at least two prior lines of systemic therapy.

Accelerated Approval Status

The approvals for mantle cell lymphoma, marginal zone lymphoma, and follicular lymphoma were granted under the FDA's accelerated approval pathway. This program allows for the earlier approval of drugs that treat serious conditions and fill an unmet medical need based on clinical trial data showing an effect on a surrogate endpoint, such as the overall response rate. Continued approval for these specific uses may be contingent upon the verification of clinical benefit in confirmatory trials.

Regulatory Safety Information

As of the most recent labeling, Brukinsa does not carry a boxed warning, which is the FDA’s most serious type of warning. There is also no Risk Evaluation and Mitigation Strategy (REMS) program required for this medication. The FDA continues to monitor the safety profile of the drug through standard post-marketing surveillance.

Question 11

What should I know about Brukinsa and cost?

Accepted Answer

Factors Influencing Cost

The actual price you pay for Brukinsa depends on several factors, including your insurance plan, your treatment schedule, and the pharmacy you use. Because it is a specialty medication, it may not be available at all retail pharmacies and often requires a specialty pharmacy provider.

Generic Status

Brukinsa is a brand-name drug. There is currently no generic version of zanubrutinib available. Brand-name medications typically cost more than generic versions because of the research and development involved.

Financial Assistance

Many patients use insurance to help cover the cost of Brukinsa. For those without insurance or whose insurance does not cover the full cost, financial assistance programs may be available. These can include:

Manufacturer-sponsored patient assistance programs.

Copay savings cards for eligible patients with commercial insurance.

Support from independent charitable foundations that help with out-of-pocket costs for chronic or life-threatening conditions.

Brukinsa

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Found an Error?